ABVYX
Price
$19.02
Change
-$0.11 (-0.58%)
Updated
Oct 7 closing price
Net Assets
444.41M
RMFCX
Price
$62.10
Change
-$0.10 (-0.16%)
Updated
Oct 7 closing price
Net Assets
112.6B
Interact to see
Advertisement

ABVYX vs RMFCX

Header iconABVYX vs RMFCX Comparison
Open Charts ABVYX vs RMFCXBanner chart's image
AB Large Cap Value Advisor
Price$19.02
Change-$0.11 (-0.58%)
VolumeN/A
Net Assets444.41M
American Funds American Mutual R3
Price$62.10
Change-$0.10 (-0.16%)
VolumeN/A
Net Assets112.6B
ABVYX vs RMFCX Comparison Chart in %
View a ticker or compare two or three
VS
ABVYX vs. RMFCX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVYX is a Hold and RMFCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 113B vs. ABVYX (444M). RMFCX pays higher dividends than ABVYX: RMFCX (1.20) vs ABVYX (1.14). ABVYX was incepted earlier than RMFCX: ABVYX (25 years) vs RMFCX (23 years). RMFCX (0.91) is less costly to investors than ABVYX (0.64). ABVYX is a more actively managed with annual turnover of: 53.00 vs. RMFCX (31.00). ABVYX has a lower initial minimum investment than RMFCX: ABVYX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 8.11 vs. ABVYX (1.63). RMFCX return over 5 years is better than : 59.28 vs. ABVYX (47.46).
ABVYXRMFCXABVYX / RMFCX
Total Expense Ratio0.640.9170%
Annual Report Gross Expense Ratio0.640.9170%
Fund Existence25 years23 years-
Gain YTD12.86114.77987%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets444M113B0%
Annual Yield % from dividends1.141.2094%
Returns for 1 year1.638.1120%
Returns for 3 years30.5743.6170%
Returns for 5 years47.4659.2880%
Returns for 10 years54.4793.9058%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LXEO8.341.87
+28.90%
Lexeo Therapeutics
FRMEP25.74-0.06
-0.23%
First Merchants Corp
VMI397.23-3.13
-0.78%
Valmont Industries
UFPT196.98-4.95
-2.45%
UFP Technologies
KPTI5.77-0.39
-6.33%
Karyopharm Therapeutics Inc.